Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRSOTSE:5619 40 PB Ratio is 1.64 as of Aug. 30, 2026, which is 8% below its 10-year median of 1.78. GuruFocus rates TSE:5619 with a GF Score™ of 40/100 and a GF Value™ of 円668.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 615 Healthcare Providers & Services companies, MRSO ranks better than 59.51% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-30), MRSO's share price is 円905.00. MRSO's Book Value per Share for the quarter that ended in Jun. 2026 was 円551.28. Hence, MRSO's PB Ratio of today is 1.64.
The historical rank and industry rank for MRSO's PB Ratio or its related term are showing as below:
TSE:5619'
s PB Ratio Range Over the Past 10 Years
Min: 1.43 Med: 1.78 Max: 3.98
Current: 1.64
During the past 5 years, MRSO's highest PB Ratio was 3.98. The lowest was 1.43. And the median was 1.78.
TSE:5619's PB Ratio is ranked better than 59.51% of 615
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs TSE:5619: 1.64
During the past 12 months, MRSO's average Book Value Per Share Growth Rate was -1.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of MRSO was 24.40% per year. The lowest was 13.60% per year. And the median was 19.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MRSO PB Ratio Related Terms
MRSO PB Ratio Historical Data
* Premium members only.
The historical data trend for MRSO's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, MRSO's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRSO PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRSO's PB Ratio distribution charts can be found below:
* The bar in red indicates where MRSO's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
MRSO's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MRSO (TSE:5619) has a PB Ratio of 1.64 as of Aug. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MRSO and its competitors. This is near median its historical median of 1.78. Over the past decade, MRSO's PB Ratio has ranged from 1.43 to 3.98. According to the industry distribution chart, MRSO ranks #249 out of 615 companies in the Healthcare Providers & Services industry, placing it in the top 40.5%.
Is MRSO's PB Ratio too high?
MRSO's current PB Ratio of 1.64 is near median its 10-year median of 1.78. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 3.98. The Healthcare Providers & Services industry median PB Ratio is 1.98. MRSO's value of 1.64 is 17.2% below this industry median. Based on the distribution chart, MRSO ranks #249 out of 615 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MRSO has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MRSO's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MRSO ranks #249 out of 615 companies for PB Ratio. This puts MRSO in the upper half of its industry. The industry median PB Ratio is 1.98. MRSO's value of 1.64 is 17.2% below this benchmark. Historically, MRSO's own PB Ratio has ranged from 1.43 to 3.98 over the past decade. While the company's 10-year median is 1.78 vs. the industry median of 1.98, MRSO has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 615 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MRSO's current PB Ratio of 1.64 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MRSO and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRSO's current PB Ratio is 1.64, which is near median its own 10-year median of 1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
Based on GuruFocus' analysis, MRSO (TSE:5619) is currently considered Significantly Overvalued. The stock's GF Value™ is 円668.03, compared to a current price of 円905.00 — trading 35.5% above its estimated fair value. The current PB Ratio is 1.64, which is near median its 10-year median of 1.78 and 17.2% below the Healthcare Providers & Services industry median of 1.98. MRSO's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MRSO (TSE:5619), the current PB Ratio is 1.64 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRSO (TSE:5619) Overvalued in 2026?
Based on GuruFocus' analysis, MRSO stock appears to be overvalued.
The current stock price of 円905.00 is trading 35.5% above its estimated GF Value™ of 円668.03.
GuruFocus considers MRSO to be Significantly Overvalued.
Key valuation signals for TSE:5619:
PB Ratio: 1.64 (near median its 10-year median of 1.78)
GF Value™: 円668.03 vs. price of 円905.00 (35.5% above fair value)
Industry Position: 17.2% below the Healthcare Providers & Services median (#249 of 615)
No single metric tells the full story. See the TSE:5619 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
40GF Score
Get the complete analysis for TSE:5619
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5619 has been successfully added to your 
